• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Exploring the Importance of Biomarker Testing to Identify Genetic Variants, Correct Treatments

Commentary
Podcast

On this episode of Managed Care Cast, Kristine Ashcraft, president and founder of YouScript, explains the importance of biomarker testing to distribute proper treatments to patients and minimize adverse events.

On this episode of Managed Care Cast, we're talking with Kristine Ashcraft, the president and founder of YouScript, a tool that helps to predict adverse drug events and personalize patient care.

We discuss the lack of awareness of genetic variants among patients and the recent adoption of biomarker testing legislation in some states. This legislation will increase biomarker testing access, which will help providers to distribute the proper treatments to more patients based on identified genetic variants.

Listen above or on one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Dan Nardi
Jawad Haider Butt, MD, PhD
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Marc P. Bonaca, MD, MPH
Jaime Murillo, MD
Jason Bellet of Eko Health
Ajai Chari, MD
Nihar Desai, MD, MPH
Leigh Maria Ramos-Platt, MD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.